PDT Partners’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-314,861
Closed -$4.08M 723
2025
Q1
$4.08M Sell
314,861
-4
-0% -$53 0.29% 97
2024
Q4
$4.02M Sell
314,865
-41,250
-12% -$499K 0.36% 73
2024
Q3
$3.97M Buy
+356,115
New +$3.93M 0.35% 61
2022
Q1
Sell
-65,298
Closed -$919K 971
2021
Q4
$919K Buy
+65,298
New +$1.07M 0.07% 381

Other funds holding DVAX

PDT Partners's DVAX Position: Q2 2025 in Review

PDT Partners sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 314,861 shares — an estimated $4.08M sold.

PDT Partners first reported a position in DVAX in Q4 2021 and held it in 4 quarters. The position peaked at $4.08M in Q1 2025. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

  • PDT Partners reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
  • PDT Partners sold 314,861 Dynavax Technologies shares in Q2 2025, an estimated $4.08M.
  • PDT Partners first reported a position in Dynavax Technologies in Q4 2021 and held it in 4 quarters.
  • PDT Partners's Dynavax Technologies position peaked at $4.08M in Q1 2025.
  • 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on PDT Partners's 13F filing for Q2 2025, filed 14 Aug 2025.